Collaborations with industry
Prisma Health physicians, scientists and other professionals may collaborate with the pharmaceutical or medical device industries to help develop medical and scientific breakthroughs or provide medical expertise or education. As we lead toward advancing medicine that will benefit patient care and support our communities within South Carolina and beyond, Prisma Health strives to adhere to our promise to: Inspire health. Serve with compassion. Be the difference.
As thought leaders and experts in their fields, Prisma Health physicians and other providers are often sought by industry to consult, provide expertise, educate and otherwise share their specialized knowledge. Prisma Health assists our physicians, scientists and other professionals in collaboration with industry to benefit our patients and the public at large. At times, our work – whether it be through investigation, research, education or other means in the normal course of business – may be commercialized in partnership with industry.
To avoid any real or perceived conflict of interest and to assure professional and commercial integrity in matters as described, Prisma Health, thorough the offices of Compliance Services and Research Compliance Administration, maintains and adheres to a program that reviews disclosed financial relationships and, when appropriate, puts measures in place to manage, mitigate or eliminate potential conflicts of interest. Prisma Health publicly discloses the names of companies when (i) its physicians and other professionals receive $5,000 or more per year (or, in some cases, equity or stock options) for speaking and consulting, (ii) serve within a fiduciary role (director, trustee), (iii) receive or have the right to receive honorariums (iv) and/or hold any equity interest for their role as inventor, discoverer, developer, founder or consultant. In doing so, Prisma Health will provide information as accurately as possible about its physicians, scientists and other professionals connections with industry.
Public Health Service-Reportable Financial Conflicts of Interest
Interactions with industry are essential to our work as scientists and researchers, but can present the potential for conflicts of interest related to such activities. Where Prisma Health has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest, communication and agreement takes place in the form of oversight, and measures are placed to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
Prisma Health physicians, scientists and team members subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals, the AdvaMed Code of Ethics on Interactions with Health Care Professionals, and the Prisma Health Code of Excellence.
Patients and associates of Prisma Health are encouraged to review CMS Open Payments for additional information as well as contact the Office of Compliance Services and/or the Office of Research Compliance Administration for more information.
|Patrick McCann, MD
||Novartis Pharmaceuticals Corp/Abbott Laboratories
|Guillaume Dumont, MD
||Smith & Nephew, Inc.
|Michael Warrick, MD
||Medtronic USA, Inc.
|Daniel Clair, MD
||Medtronic Vascular, Inc.
|Jeffrey Guy, MD
|Sultan Siddique, MD
|Frances Gilliam, MD
||Boston Scientific Corp.
|Silas Holmes, MD
|John Wells, MD
||Genentech USA, Inc.
|Robert Nahouraii, MD
||Sunovion Pharmaceuticals, Inc.
|Judith Burgis, MD
||Merck Sharp & Dohme Corp.